To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
About This Bill
Committee
Latest Action · September 13, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.